Home » Tenders » Americas » USA » Oligo and Gene Production Tender, USA - 105238141

Oligo and Gene Production Tender, USA - 105238141

HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Oligo and Gene Production. The project location is USA and the tender is closing on 21 Aug 2024. The tender notice number is 75D30124Q78083, while the TOT Ref Number is 105238141. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Oligo and Gene Production

Deadline : 21 Aug 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 105238141

Document Ref. No. : 75D30124Q78083

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :xxxxxxxxx

Address : xxxxxxxxx

Email : xxxxxxxxx

Tender Details

Description

The Centers for Disease Control and Prevention (CDC) Influenza Division (ID) is responsible for developing Candidate Vaccine Viruses based on circulating and novel influenza strains. Candidate Vaccine Viruses (CVVs) are reassortant viruses that are used as the starting materials for seasonal and pandemic vaccines. To facilitate the development of the CVVs, CDC uses oligonucleotides and synthetic genes to transcribe the influenza genes to produce the CVVs.

During research on influenza CVVs, many different genes must be constructed, significantly more than is required in CVV production in most cases. The Influenza Division, therefore, requires bulk production of oligonucleotides with relaxed quality standards versus those required for actual CVV production. The sequences will still follow the natural evolution of viruses and, therefore, can still not be predicted.
Active Contract Opportunity Notice ID 75D30124Q78083 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier CENTERS FOR DISEASE CONTROL AND PREVENTION Office CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 02, 2024 08:13 am EDT
Original Date Offers Due: Aug 21, 2024 05:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Sep 05, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance: Atlanta, GA USA